Healthcare - Sector
SGMO is currently covered by 11 analysts
Sangamo Therapeutics's activity chart (see below) currently has 37 price targets and 67 ratings on display. The stock rating distribution of SGMO is 72.22% BUY, 22.22% HOLD and 5.56% SELL.
Our record on SGMO covers 13 analysts since 2008; 11 cover it today. Of the 46 price targets those analysts set on SGMO, 18 were reached (39%). The highest performance score on SGMO belongs to Jim Birchenough of Wells Fargo: 2.63, with 2 of 5 targets met in 541 days on average. The latest calls: Patrick Trucchio of H.C. Wainwright updated the call with a Buy rating on 27 Jan 2025; Nicole Germino of Truist set a target of $5 with a Buy rating on 23 Jan 2025; Jim Birchenough of Wells Fargo cut the target to $2 from $3 with a Hold rating on 2 Jan 2025. Figures as of 18 Nov 2026.
Analysts' price targets on this stock were met 44.49% of the time, taking 222.08 days on average.
Highest price target for SGMO is $2, Lowest price target is $2.
Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 27-Jan-2025. First documented stock forecast 09-Jan-2014.
Currently out of the existing stock ratings of SGMO, 2 are a SELL (5.56%), 26 are a BUY (72.22%), 8 are a HOLD (22.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
1 years 9 months 25 days ago
(27-Jan-2025)
0/7 (0%)
$7.69 (332.90%)
Buy
$5
1 years 9 months 29 days ago
(23-Jan-2025)
0/2 (0%)
$3.81 (320.17%)
Hold
$2
$3
1 years 10 months 19 days ago
(02-Jan-2025)
2/5 (40%)
$0.87 (76.99%)
541
Buy
$3
$23
1 years 10 months 21 days ago
(31-Dec-2024)
1/5 (20%)
$1.98 (194.12%)
104
Buy
$9
2 years 7 days ago
(14-Nov-2024)
2/3 (66.67%)
$6.85 (318.60%)
371
What is SGMO (Sangamo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SGMO (Sangamo Therapeutics)?
Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?
Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?
Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?